FDA Application
-
NDC Search Results on Active Ingredient: methotrexate
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
METHOTREXATE SODIUM | 50090-3418-2 | A-S Medication Solutions | ANDA201749 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 50090-3418-9 | A-S Medication Solutions | ANDA201749 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 50090-5457-2 | A-S Medication Solutions | ANDA081099 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 50090-5457-9 | A-S Medication Solutions | ANDA081099 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 50268-527-11 | AvPAK | ANDA210040 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 50268-527-15 | AvPAK | ANDA210040 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 51079-670-01 | Mylan Institutional Inc. | ANDA081235 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 51079-670-05 | Mylan Institutional Inc. | ANDA081235 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 51285-366-01 | Teva Women's Health, Inc. | ANDA040385 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 51285-367-01 | Teva Women's Health, Inc. | ANDA040385 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 51285-368-01 | Teva Women's Health, Inc. | ANDA040385 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 51285-369-01 | Teva Women's Health, Inc. | ANDA040385 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE SODIUM | 51407-121-01 | Golden State Medical Supply, Inc. | ANDA081235 | HUMAN PRESCRIPTION DRUG | ANDA |
METHOTREXATE | 52652-2001-1 | Azurity Pharmaceuticals, Inc. | NDA208400 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 52652-2001-6 | Azurity Pharmaceuticals, Inc. | NDA208400 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-010-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-010-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-010-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-010-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-012-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-012-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-012-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-012-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-015-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-015-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-015-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-015-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-017-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-017-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-017-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
1-30 | 31-60 | 61-90 | 91-120 | 121-150 | 151-170 |
-